Research Article
Impact of Mergers and Acquisitions on Innovation Performance in Listed Chinese Medicine Enterprise
@INPROCEEDINGS{10.4108/eai.27-10-2023.2341987, author={Yulin Liang and Yunli Wang and Peilin Kou and Shunlin Xu}, title={Impact of Mergers and Acquisitions on Innovation Performance in Listed Chinese Medicine Enterprise}, proceedings={Proceedings of the 4th International Conference on Economic Management and Big Data Applications, ICEMBDA 2023, October 27--29, 2023, Tianjin, China}, publisher={EAI}, proceedings_a={ICEMBDA}, year={2024}, month={1}, keywords={listed chinese medicine enterprise; technical mergers and acquisitions; fixed effect model; innovation performance}, doi={10.4108/eai.27-10-2023.2341987} }- Yulin Liang
Yunli Wang
Peilin Kou
Shunlin Xu
Year: 2024
Impact of Mergers and Acquisitions on Innovation Performance in Listed Chinese Medicine Enterprise
ICEMBDA
EAI
DOI: 10.4108/eai.27-10-2023.2341987
Abstract
Objective To provides a reference for the mergers and acquisitions activities of listed enterprises of Chinese medicine. Methods Taking listed Chinese medicine enterprise as the research object, the technical mergers and acquisitions occurred in 2010-2022 as the sample, proposed research assumptions based on literature research.. Subsequently, the empirical test was did on fixed effect model. Results The technical mergers and acquisitions had obvious promotion effect on the invention patents, sustainable inhibitory effect on the practical new patent, and no significant impact on the appearance patent and the total patent. Conclusion The technical mergers and acquisitions promoted the technological innovation of Chinese medicine enterprises. It was recommended that Chinese medicine enterprises should attach importance to the ability of integrating resources and the absorption of technical knowledge.